Sarah Goldberg, MD, MPH
Cards
About
Titles
Associate Professor of Internal Medicine (Medical Oncology)
Associate Director, Medical Oncology-Hematology Program; Research Director, Center for Thoracic Cancers; Chief, Thoracic OncologyBiography
Dr. Sarah Goldberg is an Associate Professor of Medicine in the section of Medical Oncology at the Yale School of Medicine. As a thoracic oncologist she cares for patients with cancers of the chest including lung cancer, mesothelioma and thymoma. She is the Division Chief of Thoracic Oncology, the Research Director for the Center for Thoracic Cancers, and the Associate Program Director for the Medical Oncology-Hematology Fellowship Program at Yale. She received her medical degree from Mount Sinai School of Medicine and completed a Masters in Public Health degree from the Harvard School of Public Health. She conducts clinical and translational research on lung cancer with a focus on investigating biomarkers and novel treatment strategies in non-small cell lung cancer. Her specific research interests include EGFR mutation positive lung cancer, immunotherapeutics for lung cancer, and brain metastases.
Appointments
Medical Oncology
Associate Professor on TermPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Dana-Farber Cancer Institute, Massachusetts General Hospital (2012)
- Resident
- Massachusetts General Hospital (2009)
- MD
- Mount Sinai School of Medicine (2006)
- MPH
- Harvard School of Public Health
Research
Clinical Care
Overview
Sarah Goldberg, MD, MPH, is a thoracic oncologist who cares for patients with cancers of the chest, including lung cancer. She also treats mesothelioma (cancer that affects the tissue of the lungs, heart, and abdomen) andthymoma(a type of tumor that occurs in the thymus gland, an organ in the upper chest that is part of the lymphatic system).
Dr. Goldberg says caring for patients and offering them the best quality of life are the most rewarding aspects of her job. “I enjoy offering support and care to patients with lung cancer and also getting to know their families,” she says.
She conducts clinical and translational research on lung cancer. The focus of her research is investigating biomarkers and novel treatment strategies in non-small cell lung cancer. Her specific interests include EGFR-positive lung cancer, immunotherapeutics for lung cancer, and brain metastases.
“The field of lung cancer is constantly evolving as new therapies become available,” Dr. Goldberg says.
Clinical Specialties
Fact Sheets
Non-Small Cell Lung Cancer
Learn More on Yale MedicineSquamous Cell Carcinoma
Learn More on Yale MedicineMesothelioma
Learn More on Yale MedicineRadiofrequency Ablation (RFA)
Learn More on Yale Medicine
Board Certifications
Medical Oncology
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2023
- Original Certification Date
- 2012
Yale Medicine News
Links & Media
News
- July 03, 2024Source: MedPage Today
Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer
- June 19, 2024Source: MedPage Today
Durvalumab Consolidation a 'Breakthrough' in Limited-Stage SCLC
- June 12, 2024
Yale Medical Oncology-Hematology Fellowship Graduation 2024
- June 07, 2024
Yale Cancer Center Researchers and Trainees Present at ASCO
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.